Liposomes, Part E ( Volume 391 )

Publication series :Volume 391

Author: Duzgunes   Nejat  

Publisher: Elsevier Science‎

Publication year: 2005

E-ISBN: 9780080457437

P-ISBN(Paperback): 9780121827960

P-ISBN(Hardback):  9780121827960

Subject: Q5 Biochemistry

Language: ENG

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Description

Liposomes are cellular structures made up of lipid molecules. Important as a cellular model in the study of basic biology, liposomes are also used in clinical applications such as drug delivery and virus studies. Liposomes Part E is a continuation of previous Methods in Enzymology Liposome volumes A, B, C and D.

  • One of the most highly respected publications in the field of biochemistry since 1955
  • Frequently consulted, and praised by researchers and reviewers alike
  • Truly an essential publication for anyone in any field of the life sciences

Chapter

copyright

pp.:  4 – 5

table of contents

pp.:  5 – 8

front matter

pp.:  8 – 8

Contributors to Volume 391

pp.:  8 – 12

Preface

pp.:  12 – 14

Volumes in Series

pp.:  14 – 37

Introduction: The Origins of Liposomes: Alec Bangham at Babraham

pp.:  37 – 40

body

pp.:  40 – 40

Section I: Liposomal Anticancer Agents

pp.:  40 – 42

[1] Entrapment of Small Molecules and Nucleic Acid–Based Drugs in Liposomes

pp.:  42 – 75

[2] Preparation, Characterization, and Biological Analysis of Liposomal Formulations of Vincristine

pp.:  75 – 93

[3] Lipophilic Arabinofuranosyl Cytosine Derivatives in Liposomes

pp.:  93 – 106

[4] The Liposomal Formulation of Doxorubicin

pp.:  106 – 132

[5] Preparation and Characterization of Taxane-Containing Liposomes

pp.:  132 – 153

[6] Cisplatin Nanocapsules

pp.:  153 – 160

[7] Liposomal Cytokines in the Treatment of Infectious Diseases and Cancer

pp.:  160 – 180

[8] Glucuronate-Modified, Long-Circulating Liposomes for the Delivery of Anticancer Agents

pp.:  180 – 198

[9] Liposomalized Oligopeptides in Cancer Therapy

pp.:  198 – 211

[10] Separation of Liposome-Entrapped Mitoxantrone from Nonliposomal Mitoxantrone in Plasma: Pharmacokinetics in Mice

pp.:  211 – 221

[11] Methodology and Experimental Design for the Study of Liposome-Dependent Drugs

pp.:  221 – 235

[12] Liposome-Mediated Suicide Gene Therapy in Humans

pp.:  235 – 244

Section II: Liposomal Antibacterial, Antifungal, and Antiviral Agents

pp.:  244 – 246

[13] Use of Liposomes to Deliver Bactericides to Bacterial Biofilms

pp.:  246 – 263

[14] Long-Circulating Sterically Stabilized Liposomes in the Treatment of Infections

pp.:  263 – 296

[15] Liposome-Encapsulated Antibiotics

pp.:  296 – 326

[16] Tuftsin-Bearing Liposomes as Antibiotic Carriers in Treatment of Macrophage Infections

pp.:  326 – 339

[17] Liposomal Polyene Antibiotics

pp.:  339 – 349

[18] Drug Delivery by Lipid Cochleates

pp.:  349 – 365

[19] Lymphoid Tissue Targeting of Anti-HIV Drugs Using Liposomes

pp.:  365 – 386

[20] Delivery of Antiviral Agents in Liposomes

pp.:  386 – 409

Section III: Miscellaneous Liposomal Therapies

pp.:  409 – 411

[21] Liposomal Vasoactive Intestinal Peptide

pp.:  411 – 429

[22] Liposomal Superoxide Dismutases and Their Use in the Treatment of Experimental Arthritis

pp.:  429 – 447

[23] The Use of Sterically Stabilized Liposomes to Treat Asthma

pp.:  447 – 462

Section IV: Electron Microscopy of Liposomes

pp.:  462 – 464

[24] Cryoelectron Microscopy of Liposomes

pp.:  464 – 482

back matter

pp.:  482 – 482

Author Index

pp.:  482 – 511

Subject Index

pp.:  511 – 522

index

pp.:  511 – 511

The users who browse this book also browse